Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lipoprotein(a) | 25 | 2024 | 480 | 7.440 |
Why?
|
Coronary Artery Disease | 52 | 2024 | 6392 | 6.820 |
Why?
|
Cardiovascular Diseases | 60 | 2024 | 15499 | 4.350 |
Why?
|
Menopause, Premature | 6 | 2023 | 124 | 3.450 |
Why?
|
Genome-Wide Association Study | 82 | 2024 | 12666 | 3.420 |
Why?
|
Multifactorial Inheritance | 21 | 2024 | 1392 | 3.030 |
Why?
|
Atherosclerosis | 27 | 2024 | 3413 | 2.840 |
Why?
|
Hematopoiesis | 26 | 2024 | 2049 | 2.760 |
Why?
|
Mendelian Randomization Analysis | 20 | 2024 | 1005 | 2.630 |
Why?
|
Dioxygenases | 11 | 2024 | 345 | 2.190 |
Why?
|
Hypertension | 13 | 2024 | 8539 | 1.970 |
Why?
|
Genetic Predisposition to Disease | 59 | 2024 | 17872 | 1.940 |
Why?
|
Primary Prevention | 7 | 2022 | 1186 | 1.830 |
Why?
|
Lipids | 16 | 2024 | 3341 | 1.820 |
Why?
|
Risk Factors | 106 | 2024 | 74152 | 1.780 |
Why?
|
Phospholipids | 5 | 2024 | 786 | 1.740 |
Why?
|
Receptors, Interleukin-6 | 5 | 2023 | 225 | 1.720 |
Why?
|
Cholesterol, LDL | 29 | 2024 | 2381 | 1.710 |
Why?
|
Hematopoietic Stem Cells | 17 | 2024 | 3396 | 1.540 |
Why?
|
Polymorphism, Single Nucleotide | 44 | 2024 | 15879 | 1.440 |
Why?
|
Hyperlipoproteinemia Type II | 8 | 2024 | 395 | 1.420 |
Why?
|
Oxidation-Reduction | 4 | 2024 | 2229 | 1.370 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 10 | 2024 | 3244 | 1.310 |
Why?
|
Hypertension, Pregnancy-Induced | 4 | 2024 | 518 | 1.300 |
Why?
|
Vascular Diseases | 5 | 2024 | 1161 | 1.270 |
Why?
|
Apolipoprotein B-100 | 5 | 2024 | 157 | 1.230 |
Why?
|
Humans | 282 | 2024 | 761326 | 1.230 |
Why?
|
Genetic Variation | 17 | 2024 | 6571 | 1.230 |
Why?
|
Triglycerides | 14 | 2024 | 2458 | 1.210 |
Why?
|
Coronary Disease | 16 | 2023 | 5919 | 1.200 |
Why?
|
Pre-Eclampsia | 5 | 2024 | 1230 | 1.160 |
Why?
|
Venous Thromboembolism | 8 | 2024 | 1866 | 1.160 |
Why?
|
Biological Specimen Banks | 14 | 2024 | 783 | 1.130 |
Why?
|
Germ-Line Mutation | 5 | 2024 | 1858 | 1.120 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 515 | 1.060 |
Why?
|
Mutation | 38 | 2024 | 30044 | 1.040 |
Why?
|
Cholesterol Ester Transfer Proteins | 4 | 2023 | 113 | 1.040 |
Why?
|
Pneumonia | 3 | 2022 | 2140 | 1.000 |
Why?
|
Blood Pressure | 13 | 2024 | 8485 | 0.960 |
Why?
|
Manipulation, Osteopathic | 1 | 2024 | 3 | 0.940 |
Why?
|
Dyslipidemias | 4 | 2024 | 868 | 0.940 |
Why?
|
Middle Aged | 99 | 2024 | 220774 | 0.920 |
Why?
|
Genome, Human | 8 | 2021 | 4423 | 0.890 |
Why?
|
Coronary Vessel Anomalies | 2 | 2024 | 308 | 0.890 |
Why?
|
Female | 138 | 2024 | 392485 | 0.880 |
Why?
|
Heart Failure | 13 | 2024 | 11672 | 0.870 |
Why?
|
Chromosomes, Human, X | 2 | 2024 | 321 | 0.850 |
Why?
|
Eclampsia | 1 | 2023 | 56 | 0.840 |
Why?
|
Apolipoprotein C-III | 4 | 2024 | 209 | 0.830 |
Why?
|
Photoplethysmography | 2 | 2020 | 60 | 0.820 |
Why?
|
Hypercholesterolemia | 8 | 2024 | 1142 | 0.810 |
Why?
|
Male | 123 | 2024 | 360621 | 0.790 |
Why?
|
Risk Assessment | 21 | 2024 | 23981 | 0.780 |
Why?
|
Genetic Pleiotropy | 2 | 2022 | 181 | 0.780 |
Why?
|
Aging | 8 | 2024 | 8704 | 0.780 |
Why?
|
Life Style | 7 | 2024 | 3915 | 0.750 |
Why?
|
Coronary Angiography | 7 | 2024 | 4472 | 0.750 |
Why?
|
Hepatitis | 1 | 2023 | 229 | 0.740 |
Why?
|
Diabetes Mellitus, Type 2 | 21 | 2024 | 12144 | 0.730 |
Why?
|
Hypertension, Pulmonary | 2 | 2022 | 1580 | 0.730 |
Why?
|
Peripheral Arterial Disease | 5 | 2024 | 1272 | 0.720 |
Why?
|
Aged | 66 | 2024 | 169179 | 0.700 |
Why?
|
Parasympathetic Nervous System | 1 | 2020 | 141 | 0.700 |
Why?
|
Aortic Aneurysm, Thoracic | 2 | 2023 | 696 | 0.680 |
Why?
|
Secondary Prevention | 3 | 2024 | 1474 | 0.670 |
Why?
|
Cholesterol, HDL | 9 | 2024 | 1814 | 0.670 |
Why?
|
Myocardial Infarction | 14 | 2024 | 11454 | 0.660 |
Why?
|
Hyperlipoproteinemias | 1 | 2019 | 20 | 0.660 |
Why?
|
Disease Susceptibility | 2 | 2023 | 1791 | 0.650 |
Why?
|
Menopause | 4 | 2023 | 1646 | 0.630 |
Why?
|
Adult | 73 | 2024 | 221122 | 0.620 |
Why?
|
Genetics, Population | 3 | 2024 | 939 | 0.620 |
Why?
|
Metabolomics | 3 | 2024 | 1656 | 0.620 |
Why?
|
Postmenopause | 4 | 2023 | 2513 | 0.610 |
Why?
|
Microvessels | 2 | 2024 | 575 | 0.610 |
Why?
|
DNA-Binding Proteins | 13 | 2024 | 9605 | 0.610 |
Why?
|
Genomics | 11 | 2024 | 5817 | 0.610 |
Why?
|
Microcirculation | 2 | 2024 | 1269 | 0.600 |
Why?
|
Phenotype | 27 | 2024 | 16603 | 0.600 |
Why?
|
Sympathetic Nervous System | 1 | 2020 | 518 | 0.590 |
Why?
|
Proto-Oncogene Proteins | 8 | 2024 | 4509 | 0.590 |
Why?
|
Electronic Health Records | 5 | 2024 | 4812 | 0.580 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.580 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 354 | 0.570 |
Why?
|
Ventricular Remodeling | 3 | 2024 | 1265 | 0.570 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 701 | 0.560 |
Why?
|
Apolipoproteins | 1 | 2019 | 326 | 0.550 |
Why?
|
Incidence | 15 | 2024 | 21336 | 0.550 |
Why?
|
Aortic Valve Stenosis | 6 | 2024 | 2009 | 0.550 |
Why?
|
Carotid Stenosis | 1 | 2024 | 860 | 0.550 |
Why?
|
C-Reactive Protein | 4 | 2024 | 3824 | 0.550 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2241 | 0.540 |
Why?
|
Atrial Fibrillation | 9 | 2024 | 5127 | 0.540 |
Why?
|
Apolipoprotein A-I | 4 | 2023 | 299 | 0.530 |
Why?
|
Fingers | 1 | 2019 | 507 | 0.530 |
Why?
|
Veterans | 10 | 2024 | 2647 | 0.520 |
Why?
|
Plaque, Atherosclerotic | 2 | 2024 | 1529 | 0.510 |
Why?
|
Janus Kinase 2 | 3 | 2024 | 560 | 0.510 |
Why?
|
RNA, Small Interfering | 2 | 2024 | 3428 | 0.500 |
Why?
|
Prospective Studies | 24 | 2024 | 54405 | 0.500 |
Why?
|
Risk Reduction Behavior | 1 | 2022 | 1112 | 0.500 |
Why?
|
Lipid Metabolism | 5 | 2021 | 1900 | 0.490 |
Why?
|
Models, Genetic | 5 | 2024 | 3445 | 0.490 |
Why?
|
Lipoproteins, HDL | 4 | 2023 | 675 | 0.490 |
Why?
|
Cohort Studies | 23 | 2024 | 41440 | 0.480 |
Why?
|
Penetrance | 1 | 2016 | 388 | 0.480 |
Why?
|
Disease Progression | 5 | 2024 | 13500 | 0.460 |
Why?
|
Interleukin-6 | 3 | 2024 | 3210 | 0.460 |
Why?
|
Sex Characteristics | 4 | 2024 | 2637 | 0.460 |
Why?
|
Cardiovascular System | 1 | 2021 | 835 | 0.450 |
Why?
|
Hematologic Neoplasms | 5 | 2024 | 1896 | 0.450 |
Why?
|
Disease Management | 3 | 2022 | 2504 | 0.450 |
Why?
|
Genetic Association Studies | 9 | 2022 | 2724 | 0.440 |
Why?
|
Anticholesteremic Agents | 2 | 2022 | 967 | 0.440 |
Why?
|
Coronary Stenosis | 1 | 2019 | 794 | 0.430 |
Why?
|
Health Status | 4 | 2023 | 4075 | 0.430 |
Why?
|
Asymptomatic Diseases | 3 | 2024 | 587 | 0.420 |
Why?
|
Clone Cells | 3 | 2024 | 1661 | 0.420 |
Why?
|
Inflammation | 6 | 2024 | 10760 | 0.420 |
Why?
|
Communicable Diseases | 1 | 2021 | 880 | 0.420 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1934 | 0.410 |
Why?
|
Stroke | 7 | 2024 | 9749 | 0.400 |
Why?
|
Coronary Vessels | 3 | 2024 | 3094 | 0.400 |
Why?
|
Genotype | 16 | 2024 | 12982 | 0.400 |
Why?
|
Chromosome Aberrations | 4 | 2022 | 1771 | 0.390 |
Why?
|
Lipoproteins | 4 | 2021 | 881 | 0.390 |
Why?
|
Retina | 2 | 2024 | 2656 | 0.390 |
Why?
|
Acute Kidney Injury | 1 | 2023 | 1926 | 0.370 |
Why?
|
Hypolipidemic Agents | 3 | 2021 | 609 | 0.370 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2021 | 322 | 0.370 |
Why?
|
Quantitative Trait Loci | 7 | 2024 | 2105 | 0.360 |
Why?
|
Carotid Artery Diseases | 1 | 2016 | 877 | 0.350 |
Why?
|
Inflammasomes | 3 | 2024 | 525 | 0.350 |
Why?
|
Stroke Volume | 5 | 2024 | 5497 | 0.350 |
Why?
|
Gene Frequency | 6 | 2021 | 3639 | 0.340 |
Why?
|
Receptors, LDL | 7 | 2024 | 490 | 0.340 |
Why?
|
Women's Health | 5 | 2024 | 2065 | 0.330 |
Why?
|
Proteome | 4 | 2024 | 1863 | 0.330 |
Why?
|
Mosaicism | 2 | 2024 | 475 | 0.330 |
Why?
|
Repressor Proteins | 5 | 2024 | 2985 | 0.330 |
Why?
|
Heart Ventricles | 2 | 2022 | 3816 | 0.320 |
Why?
|
DNA Damage | 1 | 2019 | 2442 | 0.320 |
Why?
|
Heart Rate | 1 | 2020 | 4197 | 0.320 |
Why?
|
HIV Infections | 3 | 2024 | 17346 | 0.320 |
Why?
|
Cause of Death | 1 | 2019 | 3685 | 0.310 |
Why?
|
Apolipoproteins B | 4 | 2023 | 386 | 0.300 |
Why?
|
Mass Screening | 2 | 2021 | 5428 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2022 | 3441 | 0.300 |
Why?
|
Medical History Taking | 2 | 2022 | 773 | 0.290 |
Why?
|
Odds Ratio | 7 | 2023 | 9639 | 0.290 |
Why?
|
Animals | 33 | 2024 | 168388 | 0.280 |
Why?
|
Sepsis | 1 | 2021 | 2587 | 0.280 |
Why?
|
Cost of Illness | 1 | 2017 | 1935 | 0.280 |
Why?
|
Proportional Hazards Models | 5 | 2024 | 12450 | 0.280 |
Why?
|
Hyperlipidemias | 2 | 2024 | 771 | 0.280 |
Why?
|
Mutation, Missense | 6 | 2024 | 2570 | 0.280 |
Why?
|
United States | 20 | 2024 | 72317 | 0.260 |
Why?
|
Pregnancy | 10 | 2024 | 29858 | 0.260 |
Why?
|
Gene Expression Profiling | 3 | 2024 | 9414 | 0.260 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3638 | 0.260 |
Why?
|
Genetic Loci | 3 | 2021 | 2628 | 0.260 |
Why?
|
Lipase | 2 | 2021 | 325 | 0.250 |
Why?
|
Mice | 24 | 2024 | 81474 | 0.250 |
Why?
|
Proteomics | 3 | 2024 | 3843 | 0.250 |
Why?
|
Cross-Sectional Studies | 11 | 2024 | 26108 | 0.250 |
Why?
|
Medical Staff, Hospital | 1 | 2009 | 601 | 0.250 |
Why?
|
Prognosis | 7 | 2024 | 29588 | 0.250 |
Why?
|
Hormone Replacement Therapy | 2 | 2022 | 751 | 0.250 |
Why?
|
Disease | 3 | 2024 | 672 | 0.250 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15262 | 0.250 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2023 | 0.240 |
Why?
|
Thrombosis | 3 | 2024 | 2942 | 0.240 |
Why?
|
Practice Guidelines as Topic | 3 | 2022 | 7389 | 0.230 |
Why?
|
Calcinosis | 2 | 2023 | 1469 | 0.230 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14597 | 0.230 |
Why?
|
Acute Coronary Syndrome | 2 | 2021 | 2191 | 0.230 |
Why?
|
Apoprotein(a) | 1 | 2023 | 17 | 0.220 |
Why?
|
Influenza Vaccines | 1 | 2011 | 767 | 0.220 |
Why?
|
Genome | 2 | 2022 | 1740 | 0.220 |
Why?
|
Diet | 1 | 2021 | 8074 | 0.220 |
Why?
|
Colchicine | 1 | 2024 | 260 | 0.210 |
Why?
|
Telemedicine | 1 | 2020 | 3041 | 0.210 |
Why?
|
Apolipoproteins A | 1 | 2023 | 95 | 0.210 |
Why?
|
Cold-Shock Response | 1 | 2022 | 16 | 0.210 |
Why?
|
Case-Control Studies | 16 | 2022 | 22124 | 0.210 |
Why?
|
Sequence Analysis, DNA | 5 | 2021 | 4740 | 0.210 |
Why?
|
Alleles | 6 | 2024 | 6909 | 0.210 |
Why?
|
Heterozygote | 6 | 2021 | 2803 | 0.210 |
Why?
|
Radon | 1 | 2024 | 87 | 0.210 |
Why?
|
Cholesterol | 4 | 2024 | 2902 | 0.190 |
Why?
|
Sex Factors | 4 | 2024 | 10551 | 0.190 |
Why?
|
Mississippi | 1 | 2021 | 95 | 0.190 |
Why?
|
Leukocytes | 3 | 2024 | 2029 | 0.190 |
Why?
|
Self Report | 2 | 2023 | 3724 | 0.190 |
Why?
|
alpha Karyopherins | 1 | 2020 | 40 | 0.180 |
Why?
|
Vascular Resistance | 1 | 2024 | 932 | 0.180 |
Why?
|
Anti-Inflammatory Agents | 1 | 2010 | 1809 | 0.180 |
Why?
|
Albumins | 1 | 2023 | 575 | 0.180 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2004 | 563 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 557 | 0.180 |
Why?
|
Nucleic Acids | 1 | 2023 | 188 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 551 | 0.180 |
Why?
|
Subcutaneous Tissue | 1 | 2021 | 132 | 0.180 |
Why?
|
Telomere | 2 | 2023 | 941 | 0.180 |
Why?
|
Micronutrients | 1 | 2023 | 381 | 0.180 |
Why?
|
Lipolysis | 1 | 2021 | 210 | 0.180 |
Why?
|
North America | 1 | 2024 | 1275 | 0.180 |
Why?
|
Aged, 80 and over | 8 | 2021 | 58946 | 0.170 |
Why?
|
Antibodies, Monoclonal | 2 | 2017 | 9180 | 0.170 |
Why?
|
Lipoprotein Lipase | 2 | 2018 | 133 | 0.170 |
Why?
|
Multigene Family | 1 | 2023 | 1077 | 0.170 |
Why?
|
Follow-Up Studies | 6 | 2022 | 39108 | 0.170 |
Why?
|
Influenza, Human | 1 | 2011 | 1521 | 0.170 |
Why?
|
Digestive System Diseases | 1 | 2021 | 151 | 0.170 |
Why?
|
Heredity | 1 | 2020 | 148 | 0.170 |
Why?
|
Giant Cell Arteritis | 1 | 2024 | 306 | 0.170 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7872 | 0.170 |
Why?
|
Dicarboxylic Acids | 1 | 2019 | 77 | 0.170 |
Why?
|
Body Mass Index | 6 | 2024 | 12949 | 0.160 |
Why?
|
Heart Diseases | 2 | 2023 | 2785 | 0.160 |
Why?
|
Periodontitis | 1 | 2024 | 562 | 0.160 |
Why?
|
Time Factors | 6 | 2024 | 39974 | 0.160 |
Why?
|
Young Adult | 11 | 2024 | 59196 | 0.160 |
Why?
|
Smoking | 4 | 2022 | 9051 | 0.160 |
Why?
|
Birth Weight | 2 | 2024 | 2100 | 0.160 |
Why?
|
Waist-Hip Ratio | 2 | 2017 | 518 | 0.160 |
Why?
|
Blood Glucose | 5 | 2021 | 6389 | 0.160 |
Why?
|
Obesity | 6 | 2024 | 12934 | 0.160 |
Why?
|
Insulin Resistance | 3 | 2024 | 3956 | 0.160 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2019 | 277 | 0.160 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2020 | 0.160 |
Why?
|
Platelet Aggregation | 1 | 2021 | 773 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2021 | 1738 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 815 | 0.150 |
Why?
|
Nutrition Surveys | 2 | 2024 | 1728 | 0.150 |
Why?
|
Life Change Events | 1 | 2023 | 952 | 0.150 |
Why?
|
Africa | 1 | 2020 | 710 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 134 | 0.150 |
Why?
|
Pathology, Molecular | 1 | 2021 | 328 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1565 | 0.150 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 1989 | 0.150 |
Why?
|
Eye Proteins | 1 | 2021 | 633 | 0.140 |
Why?
|
Benchmarking | 1 | 2024 | 1045 | 0.140 |
Why?
|
Ovariectomy | 1 | 2019 | 614 | 0.140 |
Why?
|
Aspirin | 3 | 2024 | 3134 | 0.140 |
Why?
|
Signal Transduction | 6 | 2024 | 23427 | 0.140 |
Why?
|
Hospital Records | 1 | 2017 | 93 | 0.140 |
Why?
|
Risk | 8 | 2021 | 9605 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 704 | 0.140 |
Why?
|
Pancreatitis | 1 | 2024 | 1096 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 85 | 0.140 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 100 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 515 | 0.140 |
Why?
|
Precancerous Conditions | 1 | 2023 | 978 | 0.130 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1021 | 0.130 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 175 | 0.130 |
Why?
|
Apolipoprotein E2 | 1 | 2016 | 135 | 0.130 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2022 | 829 | 0.130 |
Why?
|
Mice, Knockout | 9 | 2024 | 14409 | 0.130 |
Why?
|
Incidental Findings | 1 | 2021 | 697 | 0.130 |
Why?
|
Proteins | 2 | 2023 | 6034 | 0.130 |
Why?
|
Heart Valve Diseases | 1 | 2023 | 1037 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1198 | 0.130 |
Why?
|
Gene Silencing | 3 | 2020 | 1509 | 0.130 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 286 | 0.130 |
Why?
|
Epigenomics | 1 | 2021 | 941 | 0.120 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.120 |
Why?
|
Heart Defects, Congenital | 2 | 2022 | 4696 | 0.120 |
Why?
|
Gout | 1 | 2022 | 623 | 0.120 |
Why?
|
Gestational Age | 1 | 2024 | 3576 | 0.120 |
Why?
|
DNA | 4 | 2023 | 7216 | 0.120 |
Why?
|
Consanguinity | 1 | 2017 | 456 | 0.120 |
Why?
|
Peptide Hormones | 1 | 2016 | 132 | 0.120 |
Why?
|
Prevalence | 5 | 2024 | 15719 | 0.120 |
Why?
|
Gene Expression | 3 | 2023 | 7582 | 0.120 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2193 | 0.120 |
Why?
|
Blood Platelets | 2 | 2024 | 2481 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1203 | 0.120 |
Why?
|
Adiposity | 1 | 2024 | 1877 | 0.120 |
Why?
|
Diabetes Complications | 1 | 2021 | 1317 | 0.120 |
Why?
|
Macular Degeneration | 1 | 2022 | 1007 | 0.120 |
Why?
|
Myeloproliferative Disorders | 1 | 2020 | 613 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2023 | 11900 | 0.110 |
Why?
|
Genetic Testing | 3 | 2024 | 3538 | 0.110 |
Why?
|
Eligibility Determination | 1 | 2017 | 421 | 0.110 |
Why?
|
Genes, Dominant | 1 | 2016 | 862 | 0.110 |
Why?
|
Heart Arrest | 1 | 2024 | 1514 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 374 | 0.110 |
Why?
|
RNA-Binding Proteins | 1 | 2022 | 1897 | 0.110 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2020 | 1050 | 0.110 |
Why?
|
Confidence Intervals | 1 | 2019 | 2927 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2022 | 1064 | 0.110 |
Why?
|
Genes | 1 | 2017 | 1844 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1286 | 0.110 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2022 | 1313 | 0.110 |
Why?
|
Biological Transport | 2 | 2010 | 2090 | 0.100 |
Why?
|
Registries | 4 | 2022 | 8223 | 0.100 |
Why?
|
Exercise | 3 | 2024 | 5883 | 0.100 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2915 | 0.100 |
Why?
|
Homozygote | 1 | 2017 | 1796 | 0.100 |
Why?
|
Pilot Projects | 2 | 2024 | 8632 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1605 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2024 | 26211 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4108 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2016 | 3777 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2897 | 0.090 |
Why?
|
Sphingosine | 1 | 2013 | 308 | 0.090 |
Why?
|
Stem Cells | 1 | 2024 | 3521 | 0.090 |
Why?
|
Lysophospholipids | 1 | 2013 | 338 | 0.090 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2020 | 1230 | 0.090 |
Why?
|
Severity of Illness Index | 4 | 2024 | 15835 | 0.090 |
Why?
|
Acetyl-CoA C-Acetyltransferase | 1 | 2010 | 8 | 0.090 |
Why?
|
Neoplasms | 5 | 2024 | 22158 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1595 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6231 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2612 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2870 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2119 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2093 | 0.090 |
Why?
|
Base Sequence | 2 | 2018 | 12449 | 0.090 |
Why?
|
Databases, Factual | 3 | 2021 | 7954 | 0.090 |
Why?
|
Health Care Costs | 1 | 2023 | 3243 | 0.090 |
Why?
|
Age Factors | 3 | 2024 | 18401 | 0.090 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2471 | 0.090 |
Why?
|
Adolescent | 5 | 2023 | 88305 | 0.090 |
Why?
|
Survival Rate | 2 | 2021 | 12710 | 0.080 |
Why?
|
Premature Birth | 1 | 2022 | 1782 | 0.080 |
Why?
|
Endothelium, Vascular | 2 | 2013 | 4432 | 0.080 |
Why?
|
Gene Deletion | 1 | 2017 | 2667 | 0.080 |
Why?
|
Niacin | 1 | 2010 | 118 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2811 | 0.080 |
Why?
|
Internship and Residency | 1 | 2009 | 5877 | 0.080 |
Why?
|
Osteoclasts | 2 | 2024 | 711 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3765 | 0.080 |
Why?
|
Molecular Sequence Annotation | 2 | 2021 | 523 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2017 | 2133 | 0.080 |
Why?
|
Patient Discharge | 1 | 2021 | 3438 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3248 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.080 |
Why?
|
Estonia | 2 | 2018 | 56 | 0.080 |
Why?
|
Coronary Restenosis | 1 | 2010 | 396 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 298 | 0.070 |
Why?
|
Glycemic Index | 1 | 2010 | 396 | 0.070 |
Why?
|
Postprandial Period | 2 | 2021 | 315 | 0.070 |
Why?
|
Audiovisual Aids | 1 | 2008 | 99 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2010 | 461 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3202 | 0.070 |
Why?
|
Anatomy | 1 | 2008 | 126 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10075 | 0.070 |
Why?
|
Patient Readmission | 1 | 2020 | 3267 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5439 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2024 | 5146 | 0.060 |
Why?
|
Ventricular Function, Left | 3 | 2024 | 3878 | 0.060 |
Why?
|
Inpatients | 1 | 2017 | 2548 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20555 | 0.060 |
Why?
|
Sample Size | 2 | 2021 | 839 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2024 | 5670 | 0.060 |
Why?
|
Hospitalists | 1 | 2009 | 294 | 0.060 |
Why?
|
American Heart Association | 2 | 2022 | 1045 | 0.060 |
Why?
|
Polymorphism, Genetic | 3 | 2022 | 4286 | 0.060 |
Why?
|
Diabetic Angiopathies | 1 | 2010 | 804 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3429 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9319 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2023 | 2176 | 0.060 |
Why?
|
Demography | 2 | 2021 | 1648 | 0.060 |
Why?
|
Epigenesis, Genetic | 3 | 2024 | 3793 | 0.060 |
Why?
|
Protein Conformation | 3 | 2014 | 3969 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2017 | 3597 | 0.060 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2024 | 66 | 0.060 |
Why?
|
Ribonucleases | 1 | 2024 | 276 | 0.060 |
Why?
|
Tandem Mass Spectrometry | 2 | 2022 | 1186 | 0.060 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2023 | 80 | 0.050 |
Why?
|
Myocytes, Cardiac | 2 | 2024 | 1671 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 161 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2024 | 235 | 0.050 |
Why?
|
Physics | 1 | 2023 | 91 | 0.050 |
Why?
|
Video Recording | 1 | 2008 | 966 | 0.050 |
Why?
|
Depression | 1 | 2023 | 8122 | 0.050 |
Why?
|
Aptamers, Peptide | 1 | 2022 | 28 | 0.050 |
Why?
|
Pedigree | 2 | 2023 | 4589 | 0.050 |
Why?
|
F-Box Proteins | 1 | 2024 | 201 | 0.050 |
Why?
|
3' Untranslated Regions | 1 | 2024 | 515 | 0.050 |
Why?
|
Bradycardia | 1 | 2024 | 299 | 0.050 |
Why?
|
Child | 4 | 2023 | 80156 | 0.050 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 42 | 0.050 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5334 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Transcription Factors | 2 | 2023 | 12122 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 8592 | 0.050 |
Why?
|
Retrospective Studies | 8 | 2024 | 80575 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22154 | 0.050 |
Why?
|
Arabs | 1 | 2023 | 187 | 0.050 |
Why?
|
Peptides | 2 | 2004 | 4342 | 0.050 |
Why?
|
Sitosterols | 1 | 2020 | 8 | 0.050 |
Why?
|
Sulfhydryl Compounds | 1 | 2002 | 298 | 0.050 |
Why?
|
Protein Structure, Secondary | 1 | 2004 | 1229 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11116 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4638 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 397 | 0.050 |
Why?
|
Population Groups | 1 | 2021 | 208 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13635 | 0.040 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 107 | 0.040 |
Why?
|
Phytosterols | 1 | 2020 | 55 | 0.040 |
Why?
|
Platelet Activation | 1 | 2024 | 645 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Alendronate | 1 | 2021 | 175 | 0.040 |
Why?
|
Bone Resorption | 1 | 2024 | 723 | 0.040 |
Why?
|
Japan | 1 | 2024 | 1372 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2024 | 627 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 319 | 0.040 |
Why?
|
Membrane Transport Proteins | 2 | 2016 | 1035 | 0.040 |
Why?
|
Magnesium | 1 | 2023 | 809 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 267 | 0.040 |
Why?
|
Critical Pathways | 1 | 2023 | 474 | 0.040 |
Why?
|
Lipid Metabolism, Inborn Errors | 1 | 2020 | 123 | 0.040 |
Why?
|
Cell Lineage | 2 | 2020 | 2556 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 482 | 0.040 |
Why?
|
Lipoproteins, LDL | 1 | 2023 | 642 | 0.040 |
Why?
|
Policy | 1 | 2023 | 508 | 0.040 |
Why?
|
Italy | 1 | 2021 | 841 | 0.040 |
Why?
|
Adenosine Triphosphatases | 1 | 2023 | 833 | 0.040 |
Why?
|
Blood Proteins | 1 | 2024 | 1180 | 0.040 |
Why?
|
Troponin T | 1 | 2024 | 779 | 0.040 |
Why?
|
Norway | 1 | 2020 | 498 | 0.040 |
Why?
|
Education, Medical, Undergraduate | 1 | 2008 | 1066 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 673 | 0.040 |
Why?
|
Retinal Pigment Epithelium | 1 | 2022 | 303 | 0.040 |
Why?
|
Factor V | 1 | 2019 | 167 | 0.040 |
Why?
|
Stents | 1 | 2010 | 3179 | 0.040 |
Why?
|
Protein Transport | 1 | 2004 | 1967 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13333 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2024 | 911 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 835 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 618 | 0.040 |
Why?
|
Peripheral Vascular Diseases | 1 | 2021 | 488 | 0.040 |
Why?
|
Program Evaluation | 2 | 2021 | 2494 | 0.040 |
Why?
|
Liposomes | 1 | 2021 | 783 | 0.040 |
Why?
|
Face | 1 | 2024 | 1026 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2014 | 7852 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7049 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3420 | 0.040 |
Why?
|
Multivariate Analysis | 2 | 2024 | 12059 | 0.040 |
Why?
|
Neuregulins | 1 | 2017 | 36 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 18962 | 0.040 |
Why?
|
Leukocyte Rolling | 1 | 2017 | 69 | 0.040 |
Why?
|
Gene Targeting | 1 | 2020 | 838 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1222 | 0.040 |
Why?
|
Osteogenesis | 1 | 2024 | 1273 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1243 | 0.040 |
Why?
|
Parity | 1 | 2020 | 927 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 851 | 0.040 |
Why?
|
Postpartum Period | 1 | 2024 | 1172 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1232 | 0.030 |
Why?
|
Interleukins | 1 | 2021 | 782 | 0.030 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 127 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2021 | 2004 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2022 | 997 | 0.030 |
Why?
|
Arteries | 1 | 2021 | 1125 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1633 | 0.030 |
Why?
|
Lipoproteins, VLDL | 1 | 2017 | 201 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 306 | 0.030 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 273 | 0.030 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 942 | 0.030 |
Why?
|
Pakistan | 1 | 2017 | 293 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2023 | 2712 | 0.030 |
Why?
|
Uric Acid | 1 | 2022 | 808 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 611 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1523 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2017 | 211 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21009 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1703 | 0.030 |
Why?
|
Massachusetts | 2 | 2020 | 8837 | 0.030 |
Why?
|
Intestinal Diseases | 1 | 2020 | 504 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 204 | 0.030 |
Why?
|
Executive Function | 1 | 2024 | 1389 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1967 | 0.030 |
Why?
|
Sequence Analysis | 1 | 2016 | 240 | 0.030 |
Why?
|
Liver | 2 | 2021 | 7531 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1337 | 0.030 |
Why?
|
Metabolome | 1 | 2022 | 987 | 0.030 |
Why?
|
Computer Simulation | 2 | 2020 | 6236 | 0.030 |
Why?
|
Sulfonylurea Compounds | 1 | 2017 | 219 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1938 | 0.030 |
Why?
|
Prediabetic State | 1 | 2021 | 549 | 0.030 |
Why?
|
Glycoproteins | 1 | 2023 | 2207 | 0.030 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2017 | 348 | 0.030 |
Why?
|
Income | 1 | 2023 | 1876 | 0.030 |
Why?
|
Social Class | 1 | 2023 | 2005 | 0.030 |
Why?
|
Epistasis, Genetic | 1 | 2016 | 352 | 0.030 |
Why?
|
Antioxidants | 1 | 2002 | 1670 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2774 | 0.030 |
Why?
|
Basophils | 1 | 2016 | 405 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 740 | 0.030 |
Why?
|
Radiology | 1 | 2008 | 2113 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5871 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2044 | 0.030 |
Why?
|
Immunoblotting | 1 | 2017 | 1647 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2017 | 385 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2017 | 696 | 0.030 |
Why?
|
Potassium Channels | 1 | 2016 | 537 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1517 | 0.030 |
Why?
|
Clinical Competence | 1 | 2009 | 4793 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2023 | 2092 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2018 | 1737 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 983 | 0.030 |
Why?
|
Aortic Valve | 1 | 2023 | 1961 | 0.030 |
Why?
|
Education | 1 | 2016 | 536 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 569 | 0.030 |
Why?
|
Acute Disease | 1 | 2024 | 7238 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1127 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3572 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2016 | 1597 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1178 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 761 | 0.030 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2013 | 122 | 0.030 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2248 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4120 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2021 | 11531 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1410 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2015 | 790 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2004 | 10764 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2023 | 5778 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2017 | 1342 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 4991 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2022 | 2221 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7045 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2016 | 1152 | 0.020 |
Why?
|
Algorithms | 2 | 2024 | 14025 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2022 | 2920 | 0.020 |
Why?
|
Rare Diseases | 1 | 2016 | 621 | 0.020 |
Why?
|
Fasting | 1 | 2017 | 1602 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2960 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3075 | 0.020 |
Why?
|
Anilides | 1 | 2013 | 411 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3303 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2578 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7824 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2023 | 3204 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3512 | 0.020 |
Why?
|
Drug Costs | 1 | 2017 | 1183 | 0.020 |
Why?
|
Dietary Fats | 1 | 2017 | 1994 | 0.020 |
Why?
|
Heart | 1 | 2022 | 4405 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6473 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3357 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2392 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2021 | 64645 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2022 | 7597 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4383 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5794 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3057 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2445 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4280 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6478 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12787 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3322 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4685 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10203 | 0.020 |
Why?
|
Arthritis, Rheumatoid | 1 | 2022 | 3760 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4614 | 0.020 |
Why?
|
Patient Compliance | 1 | 2016 | 2690 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1344 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10498 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18234 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9534 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5492 | 0.010 |
Why?
|
Societies, Medical | 1 | 2016 | 3905 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2453 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3082 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4936 | 0.010 |
Why?
|
Lipoxygenase | 1 | 2002 | 72 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10715 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13251 | 0.010 |
Why?
|
Insulin | 1 | 2017 | 6595 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8312 | 0.010 |
Why?
|
Program Development | 1 | 2008 | 1298 | 0.010 |
Why?
|
Lipid Peroxidation | 1 | 2002 | 271 | 0.010 |
Why?
|
Educational Measurement | 1 | 2008 | 1254 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5202 | 0.010 |
Why?
|
Glutathione | 1 | 2002 | 582 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36202 | 0.010 |
Why?
|
Medicare | 1 | 2017 | 6758 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42251 | 0.010 |
Why?
|
Cysteine | 1 | 2002 | 892 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10431 | 0.010 |
Why?
|
Curriculum | 1 | 2008 | 3741 | 0.010 |
Why?
|
Cell Line | 1 | 2002 | 15599 | 0.000 |
Why?
|
Macrophages | 1 | 2002 | 5768 | 0.000 |
Why?
|